TuHURA Biosciences, Inc. (NASDAQ: HURA) is a Healthcare company (Biotechnology) with a market capitalization of $89M. The Maz Rating grades it against the other companies in its sector.
TuHURA Biosciences, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $1.40, TuHURA Biosciences, Inc. trades at 4.7x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -146.8%, return on invested capital of -104.9% and a free cash flow yield of -26.8%. On the balance sheet: a debt-to-equity ratio of 0.50 and a current ratio of 0.47. Over the past 52 weeks the share price ranged from $0.41 to $3.43, with a beta of -0.01.
TuHURA Biosciences, Inc. does not currently pay a dividend.
3 Wall Street analyst ratings cover the stock: 3 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.